CELLDEX THERAPEUTICS, INC. SUBSCRIPTION AGREEMENTSubscription Agreement • October 20th, 2014 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledOctober 20th, 2014 Company Industry JurisdictionThis Subscription Agreement (the “Subscription Agreement”) is made as of October 15, 2014 (the “Effective Date”) by and between BIOSYN Corporation (“BIOSYN”) and Celldex Therapeutics, Inc. (“Celldex”).